LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)

Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Neratinib
0.01
18.98 27.76 117 941 0.1243 0.3271
MN20160318_Q01
F04
MCF 10A-H2B-mCherry Neratinib
0.01
18.98 27.76 1144 941 1.2155 1.0783
MN20160318_Q01
F04
MCF 10A-H2B-mCherry Neratinib
0.01
18.98 27.76 1 941 0.0011 -0.4799
MN20160318_Q01
F13
MCF 10A-H2B-mCherry Neratinib
0.01
18.98 27.76 1248 941 1.3260 1.1142
MN20160318_Q01
F13
MCF 10A-H2B-mCherry Neratinib
0.01
20.68 27.76 205 1119 0.1832 0.4549
MN20160318_Q01
F04
MCF 10A-H2B-mCherry Neratinib
0.01
20.68 27.76 1281 1119 1.1448 1.0514
MN20160318_Q01
F04
MCF 10A-H2B-mCherry Neratinib
0.01
20.68 27.76 3 1119 0.0027 -0.3411
MN20160318_Q01
F13
MCF 10A-H2B-mCherry Neratinib
0.01
20.68 27.76 1388 1119 1.2404 1.0824
MN20160318_Q01
F13
MCF 10A-H2B-mCherry Neratinib
0.01
22.39 27.76 539 1305 0.4128 0.7056
MN20160318_Q01
F04
MCF 10A-H2B-mCherry Neratinib
0.01
22.39 27.76 1365 1305 1.0454 1.0160
MN20160318_Q01
F04
MCF 10A-H2B-mCherry Neratinib
0.01
22.39 27.76 7 1305 0.0054 -0.2196
MN20160318_Q01
F13
MCF 10A-H2B-mCherry Neratinib
0.01
22.39 27.76 1490 1305 1.1411 1.0481
MN20160318_Q01
F13
MCF 10A-H2B-mCherry Neratinib
0.01
24.09 27.76 648 1461 0.4433 0.7348
MN20160318_Q01
F04
MCF 10A-H2B-mCherry Neratinib
0.01
24.09 27.76 1443 1461 0.9873 0.9955
MN20160318_Q01
F04
MCF 10A-H2B-mCherry Neratinib
0.01
24.09 27.76 7 1461 0.0048 -0.2141
MN20160318_Q01
F13
MCF 10A-H2B-mCherry Neratinib
0.01
24.09 27.76 1589 1461 1.0871 1.0294
MN20160318_Q01
F13
MCF 10A-H2B-mCherry Neratinib
0.01
25.79 27.76 830 1605 0.5171 0.7869
MN20160318_Q01
F04
MCF 10A-H2B-mCherry Neratinib
0.01
25.79 27.76 1560 1605 0.9719 0.9903
MN20160318_Q01
F04
MCF 10A-H2B-mCherry Neratinib
0.01
25.79 27.76 11 1605 0.0069 -0.1463
MN20160318_Q01
F13
MCF 10A-H2B-mCherry Neratinib
0.01
25.79 27.76 1759 1605 1.0959 1.0315
MN20160318_Q01
F13
MCF 10A-H2B-mCherry Neratinib
0.01
27.49 27.76 980 1723 0.5687 0.8192
MN20160318_Q01
F04
MCF 10A-H2B-mCherry Neratinib
0.01
27.49 27.76 1597 1723 0.9268 0.9746
MN20160318_Q01
F04
MCF 10A-H2B-mCherry Neratinib
0.01
27.49 27.76 16 1723 0.0093 -0.0884
MN20160318_Q01
F13
MCF 10A-H2B-mCherry Neratinib
0.01
27.49 27.76 1864 1723 1.0817 1.0266
MN20160318_Q01
F13
MCF 10A-H2B-mCherry Neratinib
0.01
29.19 27.76 1154 1863 0.6194 0.8482
MN20160318_Q01
F04